Aethlon Medical, Inc. (Nasdaq:AEMD), an immunotherapeutic technology company focused on unmet needs in global health, today announced that its CEO, Jim Joyce, will present at the NYC Oncology Investor Conference on Tuesday, October 30, 2018 at 10:50 a.m. Eastern Time.
October 29, 2018
· 3 min read